The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients

American Journal of Transplantation

Volumn 2, Issue 9, 2002, Pages 850-856

  Sagedal, Solbjørg ^a   Nordal, Knut P ^a   Hartmann, Anders ^a   Sund, Ståle ^a   Scott, Helge ^a   Degré, Miklos ^a   Foss, Aksel ^a   Leivestad, Torbjørn ^a   Osnes, Kåre ^a   Fauchald, Per ^a   Rollag, Halvor ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute renal allograft rejection; Cytomegalovirus infection; Kidney transplantation

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; GANCICLOVIR; HLA ANTIGEN; STEROID; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; REOPERATION; RISK FACTOR;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; REGRESSION ANALYSIS; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036819751     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20907.x     Document Type: Article

References (19)

1. Sagedal S, Nordal KP, Hartmann A et al. A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients. Transplantation 2000; 70: 1166-1174.
2. Yilmaz S, Koskinen PK, Kallio E, Bruggeman CA, Hayry PJ, Lemstrom KB. Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression. Kidney Int 1996; 50: 526-537.
3. Tuazon TV, Schneeberger EE, Bhan AK et al. Mononuclear cells in acute allograft glomerulopathy. Am J Pathol 1987; 129: 119-132.
4. Kashyap R, Shapiro R, Jordan M, Randhawa PS. The clinical significance of cytomegaloviral inclusions in the allograft kidney. Transplantation 1999; 67: 98-103.
5. Shaver MJ, Bonsib SM, Abul-Ezz S, Barri YM. Renal allograft dysfunction associated with cytomegalovirus infection. Am J Kidney Dis 1999; 34: 942-946.
6. Toupance O, Bouedjoro-Camus MC, Carquin J et al. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses. Transpl Int 2000; 13: 413-419.
7. Lowance D, Neumayer HH, Legendre CM et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med 1999; 340: 1462-1470.
8. Leivestad T, Reisaeter AV, Brekke IB, Vartdal F, Thorsby E. The role of HLA matching in renal transplantation: experience from one center. Reviews in Immunogenetics 1999; 1: 343-350.
9. Reisaeter AV, Leivestad T, Vartdal F et al. A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to non-sensitized recipients. Transplantation 1998; 66: 523-528.
10. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422.
11. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723,
12. Rollag H, Sagedal S, Holter E, Degre M, Ariansen S, Nordal KP. Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes. Eur J Clin Microbiol Infect Dis 1998; 17: 124-127.
13. Meier-Kriesche HU, Ojo AO, Hanson JA et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 2000; 70: 1098-1100.
14. Opelz G. Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients. The Collaborative Transplant Study. Transplant Proc 1997; 29: 73-76.
15. Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994; 57: 857-859.
16. Cecka JM, Cho YW, Terasaki PI. Analyses of the UNOS Scientific Renal Transplant Registry at three years - early events affecting transplant success. Transplantation 1992; 53: 59-64.
17. Pouteil-Noble C, Ecochard R, Landrivon G et al. Cytomegalovirus infection - an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation 1993; 55: 851-857.
18. Reinke P, Fietze E, Ode-Hakim S et al. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994; 344: 1737-1738.
19. Barama A, Oza U, Panek R et al. Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants. Clin Transplant 2000; 14: 212-217